Abstract
The effects of fluoxetine (FLU) and its active metabolite, norfluoxetine (NFLU), on the polysomnogram (PSG) of nine depressed outpatients (eight with major depression; one with bipolar II, depressed phase disorder) were investigated by contrasting PSG values prior to treatment and during administration of FLU. The PSG changes were correlated with daily dose, cumulative dosage, single serum concentrations, and the total area under the serum concentration curve (AUC) of both FLU and NFLU. Fluoxetine clearly increased both stage 1 sleep time and rapid-eye-movement (REM) latency and decreased both percent REM and REM density. With a few exceptions, the cumulative dosage of FLU and the AUC of FLU and NFLU were better predictors of the changes in awake and movement time in the PSG than single-sample concentrations of FLU and NFLU taken at the time of PSG assessment.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Address reprint requests to: William A. Hendrickse, M.D., MHCRC at St. Paul Professional Bldg. I, Suite 600, 5959 Harry Hines Blvd., Dallas, Texas 75235-9101.
Rights and permissions
About this article
Cite this article
Hendrickse, W., Roffwarg, H., Grannemann, B. et al. The Effects of Fluoxetine on the Polysomnogram of Depressed Outpatients: A Pilot Study. Neuropsychopharmacol 10, 85–91 (1994). https://doi.org/10.1038/npp.1994.10
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/npp.1994.10
Keywords
This article is cited by
-
5-HT1A/1B Receptor-Mediated Effects of the Selective Serotonin Reuptake Inhibitor, Citalopram, on Sleep: Studies in 5-HT1A and 5-HT1B Knockout Mice
Neuropsychopharmacology (2003)
-
State Markers of Depression in Sleep EEG: Dependency on Drug and Gender in Patients Treated with Tianeptine or Paroxetine
Neuropsychopharmacology (2003)